Cargando…

Sclerotherapy of Intraoral Superficial Hemangioma

Hemangioma is the clinical term for a benign vascular neoplasm due to proliferation of the endothelial lining of blood vessels. Their most frequent location is the body skin and oral mucosa. One of the treatment modalities for hemangiomas is intralesional injection of sclerosing agents which cause t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ademi Abdyli, Resmije, Abdyli, Yll, Perjuci, Feriall, Gashi, Ali, Agani, Zana, Ahmedi, Jehona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141317/
https://www.ncbi.nlm.nih.gov/pubmed/27994889
http://dx.doi.org/10.1155/2016/4320102
_version_ 1782472587743330304
author Ademi Abdyli, Resmije
Abdyli, Yll
Perjuci, Feriall
Gashi, Ali
Agani, Zana
Ahmedi, Jehona
author_facet Ademi Abdyli, Resmije
Abdyli, Yll
Perjuci, Feriall
Gashi, Ali
Agani, Zana
Ahmedi, Jehona
author_sort Ademi Abdyli, Resmije
collection PubMed
description Hemangioma is the clinical term for a benign vascular neoplasm due to proliferation of the endothelial lining of blood vessels. Their most frequent location is the body skin and oral mucosa. One of the treatment modalities for hemangiomas is intralesional injection of sclerosing agents which cause the damage of blood vessels followed by their obliteration. The objective of the study was to describe the facility of application and evaluate the efficiency of sclerotherapy with aethoxysklerol 1%. Method. The case presented with intraoral submucosal hemangioma of the cheek was treated by intralesional injection of aethoxysklerol 3% diluted in water for injections at a 4 : 1 ratio (0.75%) at the first appointment and 3 : 1 (1%) at the second appointment. The effect of sclerotherapy was evaluated on the following visits in time intervals of two weeks. Results. The hemangioma disappeared without complications after the second injection of aethoxysklerol 1%. The successful results of the study were comparable to the data of literature with variations according to the used sclerosant agent, its concentration, the number of injections, and the intervals between each session. Conclusion. Since sclerotherapy is a very effective, inexpensive, and easy-to-apply treatment, it should be the treatment of choice, especially for intraoral superficial hemangiomas.
format Online
Article
Text
id pubmed-5141317
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-51413172016-12-19 Sclerotherapy of Intraoral Superficial Hemangioma Ademi Abdyli, Resmije Abdyli, Yll Perjuci, Feriall Gashi, Ali Agani, Zana Ahmedi, Jehona Case Rep Dent Case Report Hemangioma is the clinical term for a benign vascular neoplasm due to proliferation of the endothelial lining of blood vessels. Their most frequent location is the body skin and oral mucosa. One of the treatment modalities for hemangiomas is intralesional injection of sclerosing agents which cause the damage of blood vessels followed by their obliteration. The objective of the study was to describe the facility of application and evaluate the efficiency of sclerotherapy with aethoxysklerol 1%. Method. The case presented with intraoral submucosal hemangioma of the cheek was treated by intralesional injection of aethoxysklerol 3% diluted in water for injections at a 4 : 1 ratio (0.75%) at the first appointment and 3 : 1 (1%) at the second appointment. The effect of sclerotherapy was evaluated on the following visits in time intervals of two weeks. Results. The hemangioma disappeared without complications after the second injection of aethoxysklerol 1%. The successful results of the study were comparable to the data of literature with variations according to the used sclerosant agent, its concentration, the number of injections, and the intervals between each session. Conclusion. Since sclerotherapy is a very effective, inexpensive, and easy-to-apply treatment, it should be the treatment of choice, especially for intraoral superficial hemangiomas. Hindawi Publishing Corporation 2016 2016-11-23 /pmc/articles/PMC5141317/ /pubmed/27994889 http://dx.doi.org/10.1155/2016/4320102 Text en Copyright © 2016 Resmije Ademi Abdyli et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ademi Abdyli, Resmije
Abdyli, Yll
Perjuci, Feriall
Gashi, Ali
Agani, Zana
Ahmedi, Jehona
Sclerotherapy of Intraoral Superficial Hemangioma
title Sclerotherapy of Intraoral Superficial Hemangioma
title_full Sclerotherapy of Intraoral Superficial Hemangioma
title_fullStr Sclerotherapy of Intraoral Superficial Hemangioma
title_full_unstemmed Sclerotherapy of Intraoral Superficial Hemangioma
title_short Sclerotherapy of Intraoral Superficial Hemangioma
title_sort sclerotherapy of intraoral superficial hemangioma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141317/
https://www.ncbi.nlm.nih.gov/pubmed/27994889
http://dx.doi.org/10.1155/2016/4320102
work_keys_str_mv AT ademiabdyliresmije sclerotherapyofintraoralsuperficialhemangioma
AT abdyliyll sclerotherapyofintraoralsuperficialhemangioma
AT perjuciferiall sclerotherapyofintraoralsuperficialhemangioma
AT gashiali sclerotherapyofintraoralsuperficialhemangioma
AT aganizana sclerotherapyofintraoralsuperficialhemangioma
AT ahmedijehona sclerotherapyofintraoralsuperficialhemangioma